Oz-UK
Pre-clinicalMDISprint streamlines the commercialization of Metered Dose Inhaler (MDI) products through a lean methodology that optimizes product development processes. This involves concurrent execution of Chemistry, Manufacturing, and Controls (CMC) modules, minimizing interdependencies and expediting time-to-market. The comprehensive approach includes strategic collaborations for component selection, CDMO support for commercial scale manufacturing, engagement with CROs for clinical trials, and partners...
About
MDISprint streamlines the commercialization of Metered Dose Inhaler (MDI) products through a lean methodology that optimizes product development processes. This involves concurrent execution of Chemistry, Manufacturing, and Controls (CMC) modules, minimizing interdependencies and expediting time-to-market. The comprehensive approach includes strategic collaborations for component selection, CDMO support for commercial scale manufacturing, engagement with CROs for clinical trials, and partners...
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile